Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

v3.25.1
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
 12 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

NOTE 7. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

The Company’s accounts payable and accrued liabilities consist of the following:

 

 

    December 31, 2024     December 31, 2023  
Trade payables   £ 1,393,325     £ 1,847,279  
Other tax and social security     236,175       139,029  
Accrued expenses     1,011,943       1,229,419  
Amounts accrued in respect to clinical trial testing     1,177,500       1,177,500  
Other payables     488       38,613  
Total   £ 3,819,431     £ 4,431,840  

 

The fair value of accounts payable is not materially different to the book value.